A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

ClinicalTrials.gov ID: NCT06533059

Public ClinicalTrials.gov record NCT06533059. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 4, 2026, 7:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AKTive-001: A Phase 1/1b Multiple Cohort Trial of ALTA2618 in Patients With Advanced Solid Tumors With AKT1 E17K Mutation

Study identification

NCT ID: NCT06533059
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Alterome Therapeutics, Inc.; Industry
Enrollment: 110 participants

Conditions and interventions

Conditions

Interventions

ALTA2618 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 21, 2024
Primary completion: Dec 28, 2026
Completion: Dec 28, 2027
Last update posted: Mar 8, 2026

2024 – 2027

United States locations

U.S. sites: 18
U.S. states: 12
U.S. cities: 16

Facility	City	State	ZIP	Site status
Research Site	La Jolla	California	92093	Recruiting
Research Site	Los Angeles	California	90095	Recruiting
Research Site	Denver	Colorado	80218	Recruiting
Research Site	Sarasota	Florida	34232	Recruiting
Research Site	Atlanta	Georgia	30322	Recruiting
Research Site	Boston	Massachusetts	02114	Recruiting
Research Site	Boston	Massachusetts	02215	Recruiting
Research Site	St Louis	Missouri	63110	Recruiting
Research Site	Mineola	New York	11501	Recruiting
Research Site	New York	New York	10016	Recruiting
Research Site	Maumee	Ohio	43637	Recruiting
Research Site	Nashville	Tennessee	37203	Recruiting
Research Site	Dallas	Texas	75230	Withdrawn
Research Site	Houston	Texas	77030	Recruiting
Research Site #2	San Antonio	Texas	78229	Recruiting
Research Site	San Antonio	Texas	78229	Recruiting
Research Site	Fairfax	Virginia	22031	Recruiting
Research Site	Madison	Wisconsin	53792	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06533059, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 8, 2026 · Synced May 4, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06533059 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →